Participated · Equity · Mar 2026

Wisdom Bioscience, founded in 2024 with a laboratory in Daresbury, is building a platform that detects oral cancer through a simple, non-invasive test based on circulating cell-free DNA. By integrating advanced genomic technologies directly into dental workflows, the company aims to make early oral cancer screening a routine part of dental visits. Recent company milestones include assembling a Scientific Advisory Board comprised of leading figures in oncology screening and molecular diagnostics to guide product development and commercialization strategy. Proceeds from its latest funding are earmarked for continued clinical validation studies and preparing a commercial launch later in 2024. Investors such as Stephen Quake and Jay Flatley back the company, underscoring strong industry confidence. Collectively, Wisdom has secured $28 million in funding since inception, positioning it to accelerate regulatory, clinical, and go-to-market efforts.

Participated · Series A · Aug 2025

Wisdom offers an AI-powered dental RCM platform that combines AI technology, proprietary data, and highly trained billing professionals to manage insurance collections, verification, and patient billing for dental practices. The company positions itself to serve dental offices of all sizes, from private practices to multi-location dental groups. Wisdom plans to use the new funding to further enhance its technology platform, accelerate market expansion, and continue building its team. Led by CEO Stoyan Kenderov, the business emphasizes removing the pain of dealing with insurers and providing professional revenue management so dental teams can focus on care. The company was founded in 2023 and is based in San Francisco, CA. The Series A brings the company’s total financing to $28M since founding.

Participated · Equity · Mar 2025

Bluebird Kids Health is a value-based pediatric care practice that combines 24/7 access, pediatricians and care teams, convenient locations, and integrated virtual care. The company is led by CEO and Founder Chris Johnson and is based in Boston, MA. It currently operates three locations and serves roughly 20,000 active patients. Bluebird plans to expand its operations and invest in R&D to scale its care model. The company will apply its model to new, de novo practice locations and has construction already underway in Jacksonville. The recent capital raise is intended to support these expansion and R&D efforts.

Led · Seed · Jan 2025

Lanai, based in Palo Alto, California, builds an enterprise AI Navigation System that discovers AI interactions, protects sensitive data, and helps teams scale what works. The platform dynamically uncovers human-AI interactions without relying on static APIs or manual configurations, aiming to eliminate blind spots and compliance risks. Lanai was founded by enterprise veterans Lexi Reese (CEO) and Dr. Stephen Herrod, with Rajesh Raman as CTO, drawing on experience from Google, Meta, VMware, Splunk, and Gusto. The company emerged from stealth with a $10M seed round and reports working with Fortune 1000 design partners and a growing waitlist. It positions itself as a governance and enablement layer to turn shadow AI into measurable enterprise value and cites market signals—enterprise AI adoption doubled to 65% while 90% of usage remains invisible. Lanai also highlights Gartner research that organizations guiding AI properly can achieve 35% higher revenue growth.

Participated · Equity · Jul 2024

Earned Wealth operates a tech-enabled, integrated personal financial management platform that delivers wealth, tax, career advisory, insurance, and practice-level services tailored to doctors. The firm combines prognostic technology with fiduciary advisors who specialize in physicians’ unique financial decisions across medical school loan repayment, practice buy-ins, malpractice coverage, and practice sales. Earned serves more than 3,000 clients and manages over $2 billion in assets. The company intends to use new capital to expand its platform, accelerate product innovation, and pursue strategic acquisitions to broaden offerings. As part of that M&A push, Earned announced the acquisition and rebrand of Thomas Doll, adding practice-focused tax planning and retirement programs. Management says the firm will further invest in technology and its team to scale nationwide and deepen services for medical practices. Earned (formerly Forme Financial) is a wealth management platform purpose-built for physicians that emerged from beta with a rebrand and a Series A. Its core product is a proprietary wealth engine that combines a physician’s career journey with predictive technology to generate data-driven recommendations across estate planning, taxes, debt management, insurance and investments; Certified Financial Planners help physicians evaluate major career decisions. The company charges customers fees based on assets under management and earns commissions when customers purchase items such as insurance. Since its beta launch in May 2022, Earned has worked with more than 100 physicians in 24 states, with 71% of users logging in weekly and an average reported tax savings of $77,000; the CEO declined to disclose revenue. With the new funding, Earned plans to invest in hiring and technology to add more tools and features to its wealth engine and to accelerate customer acquisition. The company says it aims to become a one-stop financial advisory shop for physicians and is considering future expansion to other high-earning healthcare professionals such as dentists and to physician families, citing an estimated $13 billion annual addressable market.